✦ LIBER ✦

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer

✍ Scribed by Rosalba Torrisi; Vincenzo Bagnardi; Nicole Rotmensz; Eloise Scarano; Monica Iorfida; Paolo Veronesi; Alberto Luini; Giuseppe Viale; Armando Santoro; Marco Colleoni; Aron Goldhirsch

Book ID: 106379153
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 287 KB
Volume: 126
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1340-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumour and biological effects of let

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer

✍ Torrisi, R; Bagnardi, V; Pruneri, G; Ghisini, R; Bottiglieri, L; Magni, E; Veron 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 146 KB

Preoperative bevacizumab combined with l

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity

✍ Torrisi, R; Bagnardi, V; Cardillo, A; Bertolini, F; Scarano, E; Orlando, L; Manc 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 156 KB

Preoperative bevacizumab combined with l

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: Clinical and biological activity

✍ Goldfarb, S.B.; Dickler, M.N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Randomized Phase III Placebo-Controlled

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

✍ Wolff, A. C.; Lazar, A. A.; Bondarenko, I.; Garin, A. M.; Brincat, S.; Chow, L.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB

PCN32 COST-EFFECTIVENESS ANALYSIS OF LET

PCN32 COST-EFFECTIVENESS ANALYSIS OF LETROZOLE VERSUS TAMOXIFEN AS INITIAL ADJUVANT THERAPY IN HORMONE-RECEPTOR POSITIVE POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER IN THE UK

✍ J Karnon; TE Delea; NL Papo; V Barghout; SK Thomas; SR Johnston 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB